
A clinician scientist at LTRI @sinaihealth studying GLP-1, diabetes, obesity and the gut endocrine system Proud 🇨🇦Not going anywhere Am 🇮🇱Chai
Toronto
Joined May 2011
- Tweets33.1K
- Following1.4K
- Followers37K
- Likes8.7K
Pinned Tweet
How do GLP-1 meds improve liver health through #weightloss independent mechanisms? Here @ChusaGzlzRellan & colleagues identify Liver Sinusoidal Endothelial Cells as direct targets of semaglutide, linking LSECs to reduction of #inflammation #Fibrosis #MASH cell.com/cell-metabolism/abs…
Rare GLP1R variants (about 1:500) attenuate weight loss with semaglutide but not tirzepatide, whereas rare LOF GIPR variants have little effect on drug responses
lnkd.in/p/g_RD5nDP
Daniel J Drucker retweeted
Stopping GLP-1 treatment linked to twice the risk of heart attack, stroke or death compared with continuing, in people with type 2 diabetes and no cardiovascular disease, according to a new study.
Find out more in @LancetRH_Europe: spkl.io/60137wUtS

ALT Research in context panel for a paper published in The Lancet Regional Health - Europe entitled \"GLP-1 receptor agonist discontinuation and cardiovascular events and all-cause mortality in people with type 2 diabetes: a retrospective cohort study\". Copyright: 2026 The Author(s). Published by Elsevier Ltd. CC BY 4.0.
The FDA is informing patients and health care providers of a potential increased risk of non-arteritic anterior ischemic optic neuropathy (NAION) associated with use of glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications. FDA fda.gov/safety/medical-produ…
SYNCHRONIZE CVOT Cardiovascular safety for the GCGR-GLP-1R co-agonist survodutide yet lingering tolerability issues highlight need for more flexibe dosing going forward thelancet.com/journals/lance…
🤖 Made with AI
A real world look at neurological outcomes post minor stroke in people with T2D using TriNetX highlighting lower risk of dementia with GLP-1 medicines link.springer.com/article/10…
We live in a real world data environment that is fast and relentless. How should we incorporate real world data into the totality of evidence? Some perspectives from the REDDIE program @DiabetologiaJnl link.springer.com/article/10…
Studies of NOD and human T1D islets identify pancreatic α cells as nonprofessional antigen-presenting cells and expand the current understanding of antigen presentation in autoimmune diabetes @ScienceAdvances science.org/doi/10.1126/scia…
Retatrutide and the improvement of obstructive sleep apnea nejm.org/doi/full/10.1056/NE…
Daniel J Drucker retweeted
GLP-1 peptides protect the gut from immune injury.
Essential role of endogenous GLP-1 family peptides to reduce inflammation and restore mucosal integrity in the experimental model @DanielJDrucker @CellRepMed
cell.com/cell-reports-medici…
Will GLP-1 medicines be useful in the clinic for substance use disorders? We will soon find out @marilenharo nature.com/articles/d41586-0…
This Friday 8 am @SinaiHealth @uoftmedicine in Toronto, the 2026 Burrow Lecture, 8 am, Professor @cevansmo #Diabetes #islets
Over 6 weeks in people with MASLD inhibition of fructose metabolism has beneficial metabolic effects that extend beyond the organs that metabolize fructose @NatMetabolism
nature.com/articles/s42255-0…
Here the authors propose that a gut microbial aldehyde-alcohol dehydrogenase, AdhE, converts metformin to pharmacologically inactive products, lowering intestinal and systemic drug exposure cell.com/cell-metabolism/ful… @Cell_Metabolism
New P3 data for the oral small-molecule GLP-1 receptor agonist safiglipron in early type 2 diabetes in China @NatureMedicine
nature.com/articles/s41591-0…
Genetic variation and type 2 #diabetes New perspectives @MolMetab sciencedirect.com/science/ar… @DiabetologiaJnl
Daniel J Drucker retweeted
SCOOP: Top researchers at Columbia, Stanford, and others thought they were elected to elite scientific societies alongside Nobel laureates. The catch? The organizations are a sham.
I spent the last month investigating a massive academic scam, for @Nature
nature.com/articles/d41586-0…
A childhood window into genetic variation linked to childhood adiposity @NatureGenet nature.com/articles/s41588-0…
Cohort studies across the lifespan for type 2 #diabetes Progress, clinical implementation and future directions @DiabetologiaJnl link.springer.com/article/10…
Here the authors identify the glucagon-PKA-PDE2A-NCLX signaling axis as a key metabolic rheostat integrating mitochondrial calcium dynamics with lipid homeostasis, providing a promising therapeutic target for MASLD @MolMetab sciencedirect.com/science/ar…
The weight loss proteome in mice nature.com/articles/s42255-0… @NatMetabolism









